Skip to main content
Top
Published in: Clinical Rheumatology 2/2008

01-02-2008 | Brief Report

Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis

Authors: Valeria Riccieri, Antonio Spadaro, Leos Fuksa, Omidreza Firuzi, Luciano Saso, Guido Valesini

Published in: Clinical Rheumatology | Issue 2/2008

Login to get access

Abstract

Oxidative stress is suggested to be involved in the pathogenesis of systemic sclerosis (SSc). The aim of the present study was to clarify such a hypothesis by determination of four different plasmatic parameters of oxidative stress, and to define its role in the microvascular damage, assessed by nailfold capillaroscopy (NC). Plasma samples of 18 patients with SSc were analyzed. The biomarkers measured were: total antioxidant capacity, hydroperoxides (ROOHs), and sulfhydryl (SH) and carbonyl (CO) groups. Each patient had a detailed clinical assessment and underwent an NC. The results showed significantly increased ROOHs in SSc patients compared to control group (5.02 ± 0.24 vs 3.28 ± 0.19 μmol/l; p < 0.05). Plasmatic levels of SH groups were significantly lower in SSc (0.466 ± 0.08 mmol/l) compared to control group (0.542 ± 0.04 mmol/l; p < 0.002). Plasma levels of ROOHs correlated with the capillaroscopy semiquantitative rating scale score (p < 0.05) and with the rating system for avascular areas (p < 0.03). The levels of CO groups inversely correlated with modified Rodnan’s skin score (p < 0.039) and were lower in patients with pulmonary fibrosis (p < 0.045), while the levels of SH groups were lower in those presenting gastrointestinal involvement (p < 0.029). The obtained data indicate augmented free radical-mediated injury in SSc and also show correlations among oxidative abnormalities, some clinical findings, and signs of a more severe microvascular involvement. These results give more evidence to the connection between oxidative impairment and SSc.
Literature
1.
go back to reference Kahaleh MB, LeRoy EC (1999) Autoimmunity and vascular involvement in systemic sclerosis. Autoimmunity 31:195–214PubMedCrossRef Kahaleh MB, LeRoy EC (1999) Autoimmunity and vascular involvement in systemic sclerosis. Autoimmunity 31:195–214PubMedCrossRef
2.
go back to reference Murrell DF (1993) A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 28:78–85PubMedCrossRef Murrell DF (1993) A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 28:78–85PubMedCrossRef
3.
go back to reference Simonini G, Matucci Cerinic M, Generini S, Zoppi M, Anichini M, Cesaretti C, Pignone A, Falcini F, Lotti T, Cagnoni M (1999) Oxidative stress in systemic sclerosis. Mol Cell Biochem 196:85–91PubMedCrossRef Simonini G, Matucci Cerinic M, Generini S, Zoppi M, Anichini M, Cesaretti C, Pignone A, Falcini F, Lotti T, Cagnoni M (1999) Oxidative stress in systemic sclerosis. Mol Cell Biochem 196:85–91PubMedCrossRef
4.
go back to reference Herrick AL, Matucci Cerinic M (2001) The emergin problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 19:4–8PubMed Herrick AL, Matucci Cerinic M (2001) The emergin problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 19:4–8PubMed
5.
go back to reference Yamamoto T, Katayama I, Nishioka K (1998) Nitric oxid production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 25:314–317PubMed Yamamoto T, Katayama I, Nishioka K (1998) Nitric oxid production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 25:314–317PubMed
6.
go back to reference Matucci Cerinic M, Kahaleh MB (2002) Beauty and the beast. The nitric oxide paradox in systemic sclerosis. Rheumatology (Oxford) 41:843–847CrossRef Matucci Cerinic M, Kahaleh MB (2002) Beauty and the beast. The nitric oxide paradox in systemic sclerosis. Rheumatology (Oxford) 41:843–847CrossRef
7.
go back to reference Ahsan H, Ali A, Ali R (2003) Oxigen free radicals and systemic autoimmunity. Clin Exp Immunol 131:398–404PubMedCrossRef Ahsan H, Ali A, Ali R (2003) Oxigen free radicals and systemic autoimmunity. Clin Exp Immunol 131:398–404PubMedCrossRef
8.
go back to reference Pratico D (2001) In vivo measurement of the redox state. Lipids 36(suppl):45–47CrossRef Pratico D (2001) In vivo measurement of the redox state. Lipids 36(suppl):45–47CrossRef
9.
go back to reference Deaney CL, Feyi K, Forrest CM, Freeman A, Harman G, McDonald MS, Petrie A, Shaw SJ, Stone TW, Stoy N, Darlington LG (2001) Levels of lipid peroxidation products in a chronic inflammatory disorder. Res Commun Mol Pathol Pharmacol 110(1–2):87–95PubMed Deaney CL, Feyi K, Forrest CM, Freeman A, Harman G, McDonald MS, Petrie A, Shaw SJ, Stone TW, Stoy N, Darlington LG (2001) Levels of lipid peroxidation products in a chronic inflammatory disorder. Res Commun Mol Pathol Pharmacol 110(1–2):87–95PubMed
10.
go back to reference Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthrits Rheum 24:1159–1165CrossRef Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthrits Rheum 24:1159–1165CrossRef
11.
go back to reference Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27(1):155–160PubMed Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27(1):155–160PubMed
12.
go back to reference Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary Criteria for the Classification of Systemic Sclerosis (Scleroderma). Arthritis Rheum 23(5):581–590CrossRef Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary Criteria for the Classification of Systemic Sclerosis (Scleroderma). Arthritis Rheum 23(5):581–590CrossRef
13.
go back to reference Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, Le Roy EC (1986) A modified scleroderma skin scoring method. Clin Exp Rheumatol 4(4):367–369PubMed Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, Le Roy EC (1986) A modified scleroderma skin scoring method. Clin Exp Rheumatol 4(4):367–369PubMed
14.
go back to reference Steen VD, Powell DL, Medsger TA (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31:196–203PubMedCrossRef Steen VD, Powell DL, Medsger TA (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31:196–203PubMedCrossRef
15.
go back to reference Kabasakal Y, Elvins DM, Ring EFJ, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512PubMedCrossRef Kabasakal Y, Elvins DM, Ring EFJ, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512PubMedCrossRef
16.
go back to reference Lee P, Leung FYK, Alderice C, Armstrong SK (1983) Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 10:930–938PubMed Lee P, Leung FYK, Alderice C, Armstrong SK (1983) Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 10:930–938PubMed
17.
go back to reference Firuzi O, Giansanti L, Vento R, Seidert C, Petrucci R, Marrosu G, Agostino R, Saso L (2003) Hypochlorite scavenging activity of hydroxycinnamic acids evaluated by a rapid microplate method based on the measurement of chloramines. J Pharm Pharmacol 55:1021–1027PubMedCrossRef Firuzi O, Giansanti L, Vento R, Seidert C, Petrucci R, Marrosu G, Agostino R, Saso L (2003) Hypochlorite scavenging activity of hydroxycinnamic acids evaluated by a rapid microplate method based on the measurement of chloramines. J Pharm Pharmacol 55:1021–1027PubMedCrossRef
18.
go back to reference Firuzi O, Mladenka P, Riccieri V, Spadaro A, Petrucci R, Marrosu G, Saso L (2006) Parameters of oxidative stress status in healthy subjects; their correlations and their stability after sample collection. J Clin Lab Anal 20:139–148PubMedCrossRef Firuzi O, Mladenka P, Riccieri V, Spadaro A, Petrucci R, Marrosu G, Saso L (2006) Parameters of oxidative stress status in healthy subjects; their correlations and their stability after sample collection. J Clin Lab Anal 20:139–148PubMedCrossRef
19.
go back to reference Firuzi O, Fuksa L, Spadaro C, Bousova I, Riccieri V, Spadaro A, Petrucci R, Marrosu G, Saso L (2006) Oxidative stress parameters in different systemic rheumatic diseases. J Pharm Pharmacol 58:951–957PubMedCrossRef Firuzi O, Fuksa L, Spadaro C, Bousova I, Riccieri V, Spadaro A, Petrucci R, Marrosu G, Saso L (2006) Oxidative stress parameters in different systemic rheumatic diseases. J Pharm Pharmacol 58:951–957PubMedCrossRef
20.
go back to reference Lau CS, O’Dowd A, Belch JJ (1992) White blood cell activation in Raynaud’s phenomenon of systemic sclerosis and vibration induced white finger syndrome. Ann Rheum Dis 51:249–252PubMed Lau CS, O’Dowd A, Belch JJ (1992) White blood cell activation in Raynaud’s phenomenon of systemic sclerosis and vibration induced white finger syndrome. Ann Rheum Dis 51:249–252PubMed
21.
go back to reference Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A (2004) High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 50:2190–2193PubMedCrossRef Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A (2004) High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 50:2190–2193PubMedCrossRef
22.
go back to reference Herrick AL, Rieley F, Schofield D, Hollis S, Braganza JM, Jayson MIV (1994) Micronutrient antioxidant status in patients with primary Raynaud’s phenomenon and systemic sclerosis. J Rheumatol 21:1477–1483PubMed Herrick AL, Rieley F, Schofield D, Hollis S, Braganza JM, Jayson MIV (1994) Micronutrient antioxidant status in patients with primary Raynaud’s phenomenon and systemic sclerosis. J Rheumatol 21:1477–1483PubMed
23.
go back to reference Prior RL, Cao G (1999) In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 27:1173–1181PubMedCrossRef Prior RL, Cao G (1999) In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 27:1173–1181PubMedCrossRef
24.
go back to reference Morita A, Minami H, Sakakibara N, Sato K, Tsuji T (1996) Elevated plasma superoxide dismutase activity in patients with systemic sclerosis. J Dermatol Sci 11:196–201PubMedCrossRef Morita A, Minami H, Sakakibara N, Sato K, Tsuji T (1996) Elevated plasma superoxide dismutase activity in patients with systemic sclerosis. J Dermatol Sci 11:196–201PubMedCrossRef
25.
go back to reference Halliwell B (1995) Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 54:505–510PubMed Halliwell B (1995) Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 54:505–510PubMed
Metadata
Title
Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis
Authors
Valeria Riccieri
Antonio Spadaro
Leos Fuksa
Omidreza Firuzi
Luciano Saso
Guido Valesini
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0769-9

Other articles of this Issue 2/2008

Clinical Rheumatology 2/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.